{"database": "lobbying", "table": "lobbying_activities", "rows": [[2680508, "bd48ed63-4c99-466a-8c28-173cface19bd", "Q3", "FOLEY & LARDNER LLP", 15042, "BLINK HEALTH LTD (A BERMUDA LIMITED COMPANY)", 2021, "third_quarter", "PHA", "Market-based solutions to drug pricing and chain pharmacy barriers to generic pharmaceutical price reduction.", "HOUSE OF REPRESENTATIVES,SENATE", 50000, null, 0, 0, "2021-10-14T14:37:48.057000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2680508"], "units": {}, "query_ms": 12.268461985513568, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}